vs
ASP Isotopes Inc.（ASPI）与Outset Medical, Inc.（OM）财务数据对比。点击上方公司名可切换其他公司
Outset Medical, Inc.的季度营收约是ASP Isotopes Inc.的1.7倍（$28.9M vs $16.7M），ASP Isotopes Inc.同比增速更快（1295.7% vs -2.0%），Outset Medical, Inc.自由现金流更多（$-9.7M vs $-47.4M）
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
Outset Medical是一家专注于肾病患者透析治疗解决方案研发与商业化的医疗科技企业，其旗舰产品Tablo血液透析系统可应用于急症诊疗场景、门诊诊所及家庭透析，服务覆盖美国及部分国际市场的医疗机构与患者群体。
ASPI vs OM — 直观对比
营收规模更大
OM
是对方的1.7倍
$16.7M
营收增速更快
ASPI
高出1297.7%
-2.0%
自由现金流更多
OM
多$37.7M
$-47.4M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.7M | $28.9M |
| 净利润 | — | $-19.5M |
| 毛利率 | 12.5% | 42.4% |
| 营业利润率 | — | -61.1% |
| 净利率 | — | -67.5% |
| 营收同比 | 1295.7% | -2.0% |
| 净利润同比 | -586.8% | 24.0% |
| 每股收益（稀释后） | — | $0.33 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASPIOM
| Q4 25 | $16.7M | $28.9M | ||
| Q3 25 | $4.9M | $29.4M | ||
| Q2 25 | — | $31.4M | ||
| Q1 25 | — | $29.8M | ||
| Q4 24 | — | $29.5M | ||
| Q3 24 | — | $28.7M | ||
| Q2 24 | — | $27.4M | ||
| Q1 24 | — | $28.2M |
净利润ASPIOM
| Q4 25 | — | $-19.5M | ||
| Q3 25 | $-12.9M | $-17.8M | ||
| Q2 25 | — | $-18.5M | ||
| Q1 25 | — | $-25.8M | ||
| Q4 24 | — | $-25.6M | ||
| Q3 24 | — | $-27.9M | ||
| Q2 24 | — | $-34.5M | ||
| Q1 24 | — | $-39.9M |
毛利率ASPIOM
| Q4 25 | 12.5% | 42.4% | ||
| Q3 25 | 8.7% | 39.4% | ||
| Q2 25 | — | 37.8% | ||
| Q1 25 | — | 37.2% | ||
| Q4 24 | — | 36.5% | ||
| Q3 24 | — | 34.3% | ||
| Q2 24 | — | 35.7% | ||
| Q1 24 | — | 29.2% |
营业利润率ASPIOM
| Q4 25 | — | -61.1% | ||
| Q3 25 | -306.1% | -53.7% | ||
| Q2 25 | — | -53.7% | ||
| Q1 25 | — | -55.1% | ||
| Q4 24 | — | -74.2% | ||
| Q3 24 | — | -83.2% | ||
| Q2 24 | — | -112.3% | ||
| Q1 24 | — | -131.0% |
净利率ASPIOM
| Q4 25 | — | -67.5% | ||
| Q3 25 | -263.7% | -60.6% | ||
| Q2 25 | — | -59.0% | ||
| Q1 25 | — | -86.7% | ||
| Q4 24 | — | -87.0% | ||
| Q3 24 | — | -97.5% | ||
| Q2 24 | — | -125.8% | ||
| Q1 24 | — | -141.8% |
每股收益（稀释后）ASPIOM
| Q4 25 | — | $0.33 | ||
| Q3 25 | $-0.15 | $-1.00 | ||
| Q2 25 | — | $-1.04 | ||
| Q1 25 | — | $-3.66 | ||
| Q4 24 | — | $-7.21 | ||
| Q3 24 | — | $-8.02 | ||
| Q2 24 | — | $-9.96 | ||
| Q1 24 | — | $-11.77 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $333.3M | $168.9M |
| 总债务越低越好 | $14.4M | $96.2M |
| 股东权益账面价值 | $204.2M | $127.0M |
| 总资产 | $498.0M | $264.5M |
| 负债/权益比越低杠杆越低 | 0.07× | 0.76× |
8季度趋势，按日历期对齐
现金及短期投资ASPIOM
| Q4 25 | $333.3M | $168.9M | ||
| Q3 25 | $113.9M | $178.6M | ||
| Q2 25 | — | $184.1M | ||
| Q1 25 | — | $189.0M | ||
| Q4 24 | — | $158.7M | ||
| Q3 24 | — | $175.6M | ||
| Q2 24 | — | $194.8M | ||
| Q1 24 | — | $226.9M |
总债务ASPIOM
| Q4 25 | $14.4M | $96.2M | ||
| Q3 25 | $13.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $197.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ASPIOM
| Q4 25 | $204.2M | $127.0M | ||
| Q3 25 | $74.1M | $142.4M | ||
| Q2 25 | — | $154.8M | ||
| Q1 25 | — | $169.9M | ||
| Q4 24 | — | $26.8M | ||
| Q3 24 | — | $47.8M | ||
| Q2 24 | — | $68.6M | ||
| Q1 24 | — | $93.2M |
总资产ASPIOM
| Q4 25 | $498.0M | $264.5M | ||
| Q3 25 | $225.9M | $277.3M | ||
| Q2 25 | — | $288.8M | ||
| Q1 25 | — | $301.2M | ||
| Q4 24 | — | $275.8M | ||
| Q3 24 | — | $292.9M | ||
| Q2 24 | — | $314.5M | ||
| Q1 24 | — | $346.2M |
负债/权益比ASPIOM
| Q4 25 | 0.07× | 0.76× | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 7.36× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.8M | $-9.5M |
| 自由现金流经营现金流 - 资本支出 | $-47.4M | $-9.7M |
| 自由现金流率自由现金流/营收 | -284.7% | -33.7% |
| 资本支出强度资本支出/营收 | 57.9% | 0.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-47.1M |
8季度趋势，按日历期对齐
经营现金流ASPIOM
| Q4 25 | $-37.8M | $-9.5M | ||
| Q3 25 | $-8.9M | $-6.3M | ||
| Q2 25 | — | $-4.8M | ||
| Q1 25 | — | $-25.7M | ||
| Q4 24 | — | $-16.5M | ||
| Q3 24 | — | $-20.6M | ||
| Q2 24 | — | $-33.3M | ||
| Q1 24 | — | $-45.9M |
自由现金流ASPIOM
| Q4 25 | $-47.4M | $-9.7M | ||
| Q3 25 | $-12.0M | $-6.5M | ||
| Q2 25 | — | $-5.1M | ||
| Q1 25 | — | $-25.8M | ||
| Q4 24 | — | $-16.5M | ||
| Q3 24 | — | $-21.0M | ||
| Q2 24 | — | $-33.5M | ||
| Q1 24 | — | $-46.3M |
自由现金流率ASPIOM
| Q4 25 | -284.7% | -33.7% | ||
| Q3 25 | -245.5% | -22.0% | ||
| Q2 25 | — | -16.3% | ||
| Q1 25 | — | -86.7% | ||
| Q4 24 | — | -56.1% | ||
| Q3 24 | — | -73.1% | ||
| Q2 24 | — | -122.2% | ||
| Q1 24 | — | -164.3% |
资本支出强度ASPIOM
| Q4 25 | 57.9% | 0.8% | ||
| Q3 25 | 64.4% | 0.5% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 1.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASPI
暂无分部数据
OM
| Consumables Product | $13.5M | 47% |
| Service And Other Revenue | $9.0M | 31% |
| Consoles Product | $6.4M | 22% |
